Last 12 months
Inside the activity.
0 purchase rows · 40 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 4 |
| Dec 2025 | 0 | 4 |
| Jan 2026 | 0 | 2 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 6 |
| Jun 2026 | 0 | 15 |
| Jul 2026 | 0 | 6 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 3 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| May 17, 2023 Filed May 19, 2023 21:22 UTC |
Sharp ShaliniDirector
|
GrantRestricted Stock Unit · Derivative | 2,100 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-031127 · doc4.xml · derivative · entry 2 Sharp Shalini · CIK 0001377202 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,100 Underlying: Common Stock · 2,100 shares Expires not disclosed F2 · derivative.exercise_price: Each Restricted Stock Unit represents a contingent right to receive one share of the Issuer Common Stock. F3 · derivative.exercise_date: The Restricted Stock Units will vest in full on May 17, 2024. F3 · derivative.expiration_date: The Restricted Stock Units will vest in full on May 17, 2024. Read SEC document |
| May 17, 2023 Filed May 19, 2023 21:22 UTC |
Sharp ShaliniDirector
|
GrantNon-Qualified Stock Option · Derivative | 4,290 | $0.00 Strike: $95.27 | $0.00 |
DisclosureSEC source: 0001209191-23-031127 · doc4.xml · derivative · entry 1 Sharp Shalini · CIK 0001377202 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,290 Underlying: Common Stock · 4,290 shares Expires 2033-05-17 F1 · derivative.exercise_date: Option vests in 12 monthly installments beginning June 17, 2023. Read SEC document |
| May 17, 2023 Filed May 19, 2023 21:21 UTC |
RASTETTER WILLIAM HDirector
|
GrantNon-Qualified Stock Option · Derivative | 8,579 | $0.00 Strike: $95.27 | $0.00 |
DisclosureSEC source: 0001209191-23-031119 · doc4.xml · derivative · entry 1 RASTETTER WILLIAM H · CIK 0001205903 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,579 Underlying: Common Stock · 8,579 shares Expires 2033-05-17 F1 · derivative.exercise_date: Option vests in 12 monthly installments beginning June 17, 2023. Read SEC document |
| May 17, 2023 Filed May 19, 2023 21:20 UTC |
POPS RICHARD FDirector
|
GrantRestricted Stock Unit · Derivative | 4,199 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-031115 · doc4.xml · derivative · entry 1 POPS RICHARD F · CIK 0001126490 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,199 Underlying: Common Stock · 4,199 shares Expires not disclosed F1 · derivative.exercise_price: Each Restricted Stock Unit represents a contingent right to receive one share of the Issuer Common Stock. F2 · derivative.exercise_date: The Restricted Stock Units will vest in full on May 17, 2024. F2 · derivative.expiration_date: The Restricted Stock Units will vest in full on May 17, 2024. Read SEC document |
| May 17, 2023 Filed May 19, 2023 21:19 UTC |
Norwalk Leslie VDirector
|
GrantRestricted Stock Unit · Derivative | 2,100 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-031112 · doc4.xml · derivative · entry 2 Norwalk Leslie V · CIK 0001533568 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,100 Underlying: Common Stock · 2,100 shares Expires not disclosed F2 · derivative.exercise_price: Each Restricted Stock Unit represents a contingent right to receive one share of the Issuer Common Stock. F3 · derivative.exercise_date: The Restricted Stock Units will vest in full on May 17, 2024. F3 · derivative.expiration_date: The Restricted Stock Units will vest in full on May 17, 2024. Read SEC document |
| May 17, 2023 Filed May 19, 2023 21:19 UTC |
Norwalk Leslie VDirector
|
GrantNon-Qualified Stock Option · Derivative | 4,290 | $0.00 Strike: $95.27 | $0.00 |
DisclosureSEC source: 0001209191-23-031112 · doc4.xml · derivative · entry 1 Norwalk Leslie V · CIK 0001533568 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,290 Underlying: Common Stock · 4,290 shares Expires 2033-05-17 F1 · derivative.exercise_date: Option vests in 12 monthly installments beginning June 17, 2023. Read SEC document |
| May 17, 2023 Filed May 19, 2023 21:18 UTC |
MORROW GEORGE JDirector
|
GrantRestricted Stock Unit · Derivative | 4,199 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-031111 · doc4.xml · derivative · entry 1 MORROW GEORGE J · CIK 0001068754 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,199 Underlying: Common Stock · 4,199 shares Expires not disclosed F1 · derivative.exercise_price: Each Restricted Stock Unit represents a contingent right to receive one share of the Issuer Common Stock. F2 · derivative.exercise_date: The Restricted Stock Units will vest in full on May 17, 2024. F2 · derivative.expiration_date: The Restricted Stock Units will vest in full on May 17, 2024. Read SEC document |
| May 17, 2023 Filed May 19, 2023 21:15 UTC |
LYONS GARY ADirector
|
GrantRestricted Stock Unit · Derivative | 2,100 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-031105 · doc4.xml · derivative · entry 2 LYONS GARY A · CIK 0001123343 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,100 Underlying: Common Stock · 2,100 shares Expires not disclosed F2 · derivative.exercise_price: Each Restricted Stock Unit represents a contingent right to receive one share of the Issuer Common Stock. F3 · derivative.exercise_date: The Restricted Stock Units will vest in full on May 17, 2024. F3 · derivative.expiration_date: The Restricted Stock Units will vest in full on May 17, 2024. Read SEC document |
| May 17, 2023 Filed May 19, 2023 21:15 UTC |
LYONS GARY ADirector
|
GrantNon-Qualified Stock Option · Derivative | 4,290 | $0.00 Strike: $95.27 | $0.00 |
DisclosureSEC source: 0001209191-23-031105 · doc4.xml · derivative · entry 1 LYONS GARY A · CIK 0001123343 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,290 Underlying: Common Stock · 4,290 shares Expires 2033-05-17 F1 · derivative.exercise_date: Option vests in 12 monthly installments beginning June 17, 2023. Read SEC document |
| May 17, 2023 Filed May 19, 2023 21:16 UTC |
Mercier JohannaDirector
|
GrantRestricted Stock Unit · Derivative | 2,100 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-031107 · doc4.xml · derivative · entry 2 Mercier Johanna · CIK 0001782135 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,100 Underlying: Common Stock · 2,100 shares Expires not disclosed F2 · derivative.exercise_price: Each Restricted Stock Unit represents a contingent right to receive one share of the Issuer Common Stock. F3 · derivative.exercise_date: The Restricted Stock Units will vest in full on May 17, 2024. F3 · derivative.expiration_date: The Restricted Stock Units will vest in full on May 17, 2024. Read SEC document |
| May 17, 2023 Filed May 19, 2023 21:16 UTC |
Mercier JohannaDirector
|
GrantNon-Qualified Stock Option · Derivative | 4,290 | $0.00 Strike: $95.27 | $0.00 |
DisclosureSEC source: 0001209191-23-031107 · doc4.xml · derivative · entry 1 Mercier Johanna · CIK 0001782135 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,290 Underlying: Common Stock · 4,290 shares Expires 2033-05-17 F1 · derivative.exercise_date: Option vests in 12 monthly installments beginning June 17, 2023. Read SEC document |
| May 01, 2023 Filed May 3, 2023 21:34 UTC |
RASTETTER WILLIAM HDirector
|
Exercise / conversionNon-Qualified Stock Option · Derivative | 7,625 | $12.71 Strike: $12.71 | $96,913.75 |
DisclosureSEC source: 0001209191-23-027095 · doc4.xml · derivative · entry 3 RASTETTER WILLIAM H · CIK 0001205903 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 7,625 shares Expires 2023-05-23 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: The option was granted May 23, 2013 and vested in 12 equal monthly installments beginning June 23, 2013. Read SEC document |
| May 01, 2023 Filed May 3, 2023 21:34 UTC |
RASTETTER WILLIAM HDirector
|
SaleCommon Stock | 4,300 | $101.43 | $436,135.24 |
DisclosureSEC source: 0001209191-23-027095 · doc4.xml · nonDerivative · entry 2 RASTETTER WILLIAM H · CIK 0001205903 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 42,785 F1 · kind: The disposition reported in this Form 4 was effected by a broker pursuant to instructions set forth in a Rule 10b5-1 trading plan adopted on May 19, 2022. Additionally, Issuer policy restricts the Reporting Person from amending or otherwise modifying any 10b5-1 trading plan subsequent to adoption of the plan. F2 · price: Represents a weighted average sales price per share. These shares were sold in multiple transactions at prices ranging from $100.87 to $101.84. The Reporting Person has provided to the issuer, and will provide to any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range. F3 · balance_after: 34,022 of the reported shares are held by the Rastetter Family Trust established September 2, 2010, of which the Reporting Person has voting and investment power. Read SEC document |
| May 01, 2023 Filed May 3, 2023 21:34 UTC |
RASTETTER WILLIAM HDirector
|
Exercise / conversionCommon Stock | 7,625 | $12.71 | $96,913.75 |
DisclosureSEC source: 0001209191-23-027095 · doc4.xml · nonDerivative · entry 1 RASTETTER WILLIAM H · CIK 0001205903 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 47,085 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 01, 2023 Filed May 3, 2023 21:28 UTC |
Cooke JulieChief Human Resources Officer
|
SaleCommon Stock | 11,397 | $103.89 | $1,184,049.15 |
DisclosureSEC source: 0001209191-23-027089 · doc4.xml · nonDerivative · entry 1 Cooke Julie · CIK 0001776977 · Chief Human Resources Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 16,169 F1 · kind: The disposition reported in this Form 4 was effected by a broker pursuant to instructions set forth in a Rule 10b5-1 trading plan adopted on February 24, 2023. Additionally, Issuer policy restricts the Reporting Person from amending or otherwise modifying any 10b5-1 trading plan subsequent to adoption of the plan. F2 · price: Represents a weighted average sales price per share. These shares were sold in multiple transactions at prices ranging from $103.82 to $104.12. The Reporting Person has provided to the issuer, and will provide to any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range. Read SEC document |
| April 25, 2023 Filed Apr 27, 2023 20:37 UTC |
Cooke JulieChief Human Resources Officer
|
SaleCommon Stock | 100 | $103.82 | $10,382.00 |
DisclosureSEC source: 0001209191-23-025862 · doc4.xml · nonDerivative · entry 1 Cooke Julie · CIK 0001776977 · Chief Human Resources Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 27,561 F1 · kind: The disposition reported in this Form 4 was effected by a broker pursuant to instructions set forth in a Rule 10b5-1 trading plan adopted on February 24, 2023. Additionally, Issuer policy restricts the Reporting Person from amending or otherwise modifying any 10b5-1 trading plan subsequent to adoption of the plan. F2 · balance_after: Includes an aggregate of 237 shares purchased on February 28, 2023 from the Neurocrine Biosciences, Inc. 2018 Employee Stock Purchase Plan. Read SEC document |
| April 24, 2023 Filed Apr 27, 2023 01:22 UTC |
ROBERTS EIRYChief Medical Officer
|
SaleCommon Stock | 14,400 | $103.48 | $1,490,058.72 |
DisclosureSEC source: 0001209191-23-025763 · doc4.xml · nonDerivative · entry 1 ROBERTS EIRY · CIK 0001727606 · Chief Medical Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 26,644 F1 · kind: The disposition reported in this Form 4 was effected by a broker pursuant to instructions set forth in a Rule 10b5-1 trading plan adopted on February 23, 2023. Additionally, Issuer policy restricts the Reporting Person from amending or otherwise modifying any 10b5-1 trading plan subsequent to adoption of the plan. F2 · price: Represents a weighted average sales price per share. These shares were sold in multiple transactions at prices ranging from $102.84 to $104.15. The Reporting Person has provided to the issuer, and will provide to any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range. Read SEC document |
| April 21, 2023 Filed Apr 21, 2023 22:58 UTC |
RASTETTER WILLIAM HDirector
|
Exercise / conversionNon-Qualified Stock Option · Derivative | 10,765 | $12.71 Strike: $12.71 | $136,823.15 |
DisclosureSEC source: 0001209191-23-025273 · doc4.xml · derivative · entry 6 RASTETTER WILLIAM H · CIK 0001205903 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 7,625 Underlying: Common Stock · 10,765 shares Expires 2023-05-23 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: The option was granted May 23, 2013 and vested in 12 equal monthly installments beginning June 23, 2013. Read SEC document |
| April 21, 2023 Filed Apr 21, 2023 22:58 UTC |
RASTETTER WILLIAM HDirector
|
SaleCommon Stock | 6,034 | $105.04 | $633,786.62 |
DisclosureSEC source: 0001209191-23-025273 · doc4.xml · nonDerivative · entry 4 RASTETTER WILLIAM H · CIK 0001205903 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 39,460 F1 · kind: The disposition reported in this Form 4 was effected by a broker pursuant to instructions set forth in a Rule 10b5-1 trading plan adopted on May 19, 2022. Additionally, Issuer policy restricts the Reporting Person from amending or otherwise modifying any 10b5-1 trading plan subsequent to adoption of the plan. F3 · price: Represents a weighted average sales price per share. These shares were sold in multiple transactions at prices ranging from $105.00 to $105.11. The Reporting Person has provided to the issuer, and will provide to any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range. F4 · ownership.direct: 34,022 of the reported shares are held by the Rastetter Family Trust established September 2, 2010, of which the Reporting Person has voting and investment power. Read SEC document |
| April 21, 2023 Filed Apr 21, 2023 22:58 UTC |
RASTETTER WILLIAM HDirector
|
Exercise / conversionCommon Stock | 10,765 | $12.71 | $136,823.15 |
DisclosureSEC source: 0001209191-23-025273 · doc4.xml · nonDerivative · entry 3 RASTETTER WILLIAM H · CIK 0001205903 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 45,494 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| April 19, 2023 Filed Apr 21, 2023 22:58 UTC |
RASTETTER WILLIAM HDirector
|
Exercise / conversionNon-Qualified Stock Option · Derivative | 1,610 | $12.71 Strike: $12.71 | $20,463.10 |
DisclosureSEC source: 0001209191-23-025273 · doc4.xml · derivative · entry 5 RASTETTER WILLIAM H · CIK 0001205903 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 18,390 Underlying: Common Stock · 1,610 shares Expires 2023-05-23 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: The option was granted May 23, 2013 and vested in 12 equal monthly installments beginning June 23, 2013. Read SEC document |
| April 19, 2023 Filed Apr 21, 2023 22:58 UTC |
RASTETTER WILLIAM HDirector
|
SaleCommon Stock | 903 | $105.00 | $94,818.61 |
DisclosureSEC source: 0001209191-23-025273 · doc4.xml · nonDerivative · entry 2 RASTETTER WILLIAM H · CIK 0001205903 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 34,729 F1 · kind: The disposition reported in this Form 4 was effected by a broker pursuant to instructions set forth in a Rule 10b5-1 trading plan adopted on May 19, 2022. Additionally, Issuer policy restricts the Reporting Person from amending or otherwise modifying any 10b5-1 trading plan subsequent to adoption of the plan. F2 · price: Represents a weighted average sales price per share. These shares were sold in multiple transactions at prices ranging from $105.00 to $105.04. The Reporting Person has provided to the issuer, and will provide to any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range. Read SEC document |
| April 19, 2023 Filed Apr 21, 2023 22:58 UTC |
RASTETTER WILLIAM HDirector
|
Exercise / conversionCommon Stock | 1,610 | $12.71 | $20,463.10 |
DisclosureSEC source: 0001209191-23-025273 · doc4.xml · nonDerivative · entry 1 RASTETTER WILLIAM H · CIK 0001205903 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 35,632 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 13, 2023 Filed Feb 16, 2023 00:32 UTC |
Delaet IngridChief Regulatory Officer
|
GrantRestricted Stock Unit · Derivative | 5,434 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-009901 · doc4.xml · derivative · entry 2 Delaet Ingrid · CIK 0001965808 · Chief Regulatory Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,434 Underlying: Common Stock · 5,434 shares Expires not disclosed F2 · derivative.exercise_price: Each Restricted Stock Unit represents a contingent right to receive one share of the Issuer Common Stock. F3 · derivative.exercise_date: The Restricted Stock Units will vest annually at 1/4 of the units vesting on each of February 13, 2024, February 13, 2025, February 13, 2026, and February 13, 2027. F3 · derivative.expiration_date: The Restricted Stock Units will vest annually at 1/4 of the units vesting on each of February 13, 2024, February 13, 2025, February 13, 2026, and February 13, 2027. Read SEC document |
| February 13, 2023 Filed Feb 16, 2023 00:32 UTC |
Delaet IngridChief Regulatory Officer
|
GrantStock Option · Derivative | 33,771 | $0.00 Strike: $103.52 | $0.00 |
DisclosureSEC source: 0001209191-23-009901 · doc4.xml · derivative · entry 1 Delaet Ingrid · CIK 0001965808 · Chief Regulatory Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 33,771 Underlying: Common Stock · 33,771 shares Expires 2033-02-13 F1 · derivative.exercise_date: Represents option of which 1/48th of the shares underlying the option becomes vested and exercisable on March 13, 2023 and an additional 1/48th of the shares underlying the option becomes vested and exercisable each month thereafter. Read SEC document |
| February 13, 2023 Filed Feb 16, 2023 00:15 UTC |
ROBERTS EIRYChief Medical Officer
|
GrantRestricted Stock Unit · Derivative | 8,453 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-009889 · doc4.xml · derivative · entry 2 ROBERTS EIRY · CIK 0001727606 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,453 Underlying: Common Stock · 8,453 shares Expires not disclosed F2 · derivative.exercise_price: Each Restricted Stock Unit represents a contingent right to receive one share of the Issuer Common Stock. F3 · derivative.exercise_date: The Restricted Stock Units will vest annually at 1/4 of the units vesting on each of February 13, 2024, February 13, 2025, February 13, 2026, and February 13, 2027. F3 · derivative.expiration_date: The Restricted Stock Units will vest annually at 1/4 of the units vesting on each of February 13, 2024, February 13, 2025, February 13, 2026, and February 13, 2027. Read SEC document |
| February 13, 2023 Filed Feb 16, 2023 00:15 UTC |
ROBERTS EIRYChief Medical Officer
|
GrantStock Option · Derivative | 52,532 | $0.00 Strike: $103.52 | $0.00 |
DisclosureSEC source: 0001209191-23-009889 · doc4.xml · derivative · entry 1 ROBERTS EIRY · CIK 0001727606 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 52,532 Underlying: Common Stock · 52,532 shares Expires 2033-02-13 F1 · derivative.exercise_date: Represents option of which 1/48th of the shares underlying the option becomes vested and exercisable on March 13, 2023 and an additional 1/48th of the shares underlying the option becomes vested and exercisable each month thereafter. Read SEC document |
| February 13, 2023 Filed Feb 16, 2023 00:14 UTC |
Onyia JudeChief Scientific Officer
|
GrantRestricted Stock Unit · Derivative | 10,868 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-009888 · doc4.xml · derivative · entry 2 Onyia Jude · CIK 0001894425 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,868 Underlying: Common Stock · 10,868 shares Expires not disclosed F2 · derivative.exercise_price: Each Restricted Stock Unit represents a contingent right to receive one share of the Issuer Common Stock. F3 · derivative.exercise_date: The Restricted Stock Units will vest annually at 1/4 of the units vesting on each of February 13, 2024, February 13, 2025, February 13, 2026, and February 13, 2027. F3 · derivative.expiration_date: The Restricted Stock Units will vest annually at 1/4 of the units vesting on each of February 13, 2024, February 13, 2025, February 13, 2026, and February 13, 2027. Read SEC document |
| February 13, 2023 Filed Feb 16, 2023 00:14 UTC |
Onyia JudeChief Scientific Officer
|
GrantStock Option · Derivative | 67,541 | $0.00 Strike: $103.52 | $0.00 |
DisclosureSEC source: 0001209191-23-009888 · doc4.xml · derivative · entry 1 Onyia Jude · CIK 0001894425 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 67,541 Underlying: Common Stock · 67,541 shares Expires 2033-02-13 F1 · derivative.exercise_date: Represents option of which 1/48th of the shares underlying the option becomes vested and exercisable on March 13, 2023 and an additional 1/48th of the shares underlying the option becomes vested and exercisable each month thereafter. Read SEC document |
| February 13, 2023 Filed Feb 16, 2023 00:10 UTC |
Gano KyleChief Business Development Off
|
GrantRestricted Stock Unit · Derivative | 10,264 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-009884 · doc4.xml · derivative · entry 2 Gano Kyle · CIK 0001567160 · Chief Business Development Off 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,264 Underlying: Common Stock · 10,264 shares Expires not disclosed F2 · derivative.exercise_price: Each Restricted Stock Unit represents a contingent right to receive one share of the Issuer Common Stock. F3 · derivative.exercise_date: The Restricted Stock Units will vest annually at 1/4 of the units vesting on each of February 13, 2024, February 13, 2025, February 13, 2026, and February 13, 2027. F3 · derivative.expiration_date: The Restricted Stock Units will vest annually at 1/4 of the units vesting on each of February 13, 2024, February 13, 2025, February 13, 2026, and February 13, 2027. Read SEC document |
| February 13, 2023 Filed Feb 16, 2023 00:10 UTC |
Gano KyleChief Business Development Off
|
GrantStock Option · Derivative | 63,789 | $0.00 Strike: $103.52 | $0.00 |
DisclosureSEC source: 0001209191-23-009884 · doc4.xml · derivative · entry 1 Gano Kyle · CIK 0001567160 · Chief Business Development Off 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 63,789 Underlying: Common Stock · 63,789 shares Expires 2033-02-13 F1 · derivative.exercise_date: Represents option of which 1/48th of the shares underlying the option becomes vested and exercisable on March 13, 2023 and an additional 1/48th of the shares underlying the option becomes vested and exercisable each month thereafter. Read SEC document |
| February 13, 2023 Filed Feb 16, 2023 00:08 UTC |
Cooke JulieChief Human Resources Officer
|
GrantRestricted Stock Unit · Derivative | 6,038 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-009883 · doc4.xml · derivative · entry 2 Cooke Julie · CIK 0001776977 · Chief Human Resources Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,038 Underlying: Common Stock · 6,038 shares Expires not disclosed F2 · derivative.exercise_price: Each Restricted Stock Unit represents a contingent right to receive one share of the Issuer Common Stock. F3 · derivative.exercise_date: The Restricted Stock Units will vest annually at 1/4 of the units vesting on each of February 13, 2024, February 13, 2025, February 13, 2026, and February 13, 2027. F3 · derivative.expiration_date: The Restricted Stock Units will vest annually at 1/4 of the units vesting on each of February 13, 2024, February 13, 2025, February 13, 2026, and February 13, 2027. Read SEC document |
| February 13, 2023 Filed Feb 16, 2023 00:08 UTC |
Cooke JulieChief Human Resources Officer
|
GrantStock Option · Derivative | 37,523 | $0.00 Strike: $103.52 | $0.00 |
DisclosureSEC source: 0001209191-23-009883 · doc4.xml · derivative · entry 1 Cooke Julie · CIK 0001776977 · Chief Human Resources Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37,523 Underlying: Common Stock · 37,523 shares Expires 2033-02-13 F1 · derivative.exercise_date: Represents option of which 1/48th of the shares underlying the option becomes vested and exercisable on March 13, 2023 and an additional 1/48th of the shares underlying the option becomes vested and exercisable each month thereafter. Read SEC document |
| February 13, 2023 Filed Feb 16, 2023 00:11 UTC |
GORMAN KEVIN CHARLESDirector · Chief Executive Officer
|
GrantRestricted Stock Unit · Derivative | 21,506 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-009886 · doc4.xml · derivative · entry 2 GORMAN KEVIN CHARLES · CIK 0001201096 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,506 Underlying: Common Stock · 21,506 shares Expires not disclosed F2 · derivative.exercise_price: Each Restricted Stock Unit represents a contingent right to receive one share of the Issuer Common Stock. F3 · derivative.exercise_date: The Restricted Stock Units will vest annually at 1/4 of the units vesting on each of February 13, 2024, February 13, 2025, February 13, 2026, and February 13, 2027. F3 · derivative.expiration_date: The Restricted Stock Units will vest annually at 1/4 of the units vesting on each of February 13, 2024, February 13, 2025, February 13, 2026, and February 13, 2027. Read SEC document |
| February 13, 2023 Filed Feb 16, 2023 00:11 UTC |
GORMAN KEVIN CHARLESDirector · Chief Executive Officer
|
GrantStock Option · Derivative | 133,656 | $0.00 Strike: $103.52 | $0.00 |
DisclosureSEC source: 0001209191-23-009886 · doc4.xml · derivative · entry 1 GORMAN KEVIN CHARLES · CIK 0001201096 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 133,656 Underlying: Common Stock · 133,656 shares Expires 2033-02-13 F1 · derivative.exercise_date: Represents option of which 1/48th of the shares underlying the option becomes vested and exercisable on March 13, 2023 and an additional 1/48th of the shares underlying the option becomes vested and exercisable each month thereafter. Read SEC document |
| February 13, 2023 Filed Feb 16, 2023 00:13 UTC |
Lippoldt DarinChief Legal Officer
|
GrantRestricted Stock Unit · Derivative | 8,332 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-009887 · doc4.xml · derivative · entry 2 Lippoldt Darin · CIK 0001504783 · Chief Legal Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,332 Underlying: Common Stock · 8,332 shares Expires not disclosed F2 · derivative.exercise_price: Each Restricted Stock Unit represents a contingent right to receive one share of the Issuer Common Stock. F3 · derivative.exercise_date: The Restricted Stock Units will vest annually at 1/4 of the units vesting on each of February 13, 2024, February 13, 2025, February 13, 2026, and February 13, 2027. F3 · derivative.expiration_date: The Restricted Stock Units will vest annually at 1/4 of the units vesting on each of February 13, 2024, February 13, 2025, February 13, 2026, and February 13, 2027. Read SEC document |
| February 13, 2023 Filed Feb 16, 2023 00:13 UTC |
Lippoldt DarinChief Legal Officer
|
GrantStock Option · Derivative | 51,782 | $0.00 Strike: $103.52 | $0.00 |
DisclosureSEC source: 0001209191-23-009887 · doc4.xml · derivative · entry 1 Lippoldt Darin · CIK 0001504783 · Chief Legal Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 51,782 Underlying: Common Stock · 51,782 shares Expires 2033-02-13 F1 · derivative.exercise_date: Represents option of which 1/48th of the shares underlying the option becomes vested and exercisable on March 13, 2023 and an additional 1/48th of the shares underlying the option becomes vested and exercisable each month thereafter. Read SEC document |
| February 13, 2023 Filed Feb 16, 2023 00:07 UTC |
Boyer David W.Chief Corp. Affairs Officer
|
GrantRestricted Stock Unit · Derivative | 7,245 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-009882 · doc4.xml · derivative · entry 2 Boyer David W. · CIK 0001909817 · Chief Corp. Affairs Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,245 Underlying: Common Stock · 7,245 shares Expires not disclosed F2 · derivative.exercise_price: Each Restricted Stock Unit represents a contingent right to receive one share of the Issuer Common Stock. F3 · derivative.exercise_date: The Restricted Stock Units will vest annually at 1/4 of the units vesting on each of February 13, 2024, February 13, 2025, February 13, 2026, and February 13, 2027. F3 · derivative.expiration_date: The Restricted Stock Units will vest annually at 1/4 of the units vesting on each of February 13, 2024, February 13, 2025, February 13, 2026, and February 13, 2027. Read SEC document |
| February 13, 2023 Filed Feb 16, 2023 00:07 UTC |
Boyer David W.Chief Corp. Affairs Officer
|
GrantStock Option · Derivative | 45,027 | $0.00 Strike: $103.52 | $0.00 |
DisclosureSEC source: 0001209191-23-009882 · doc4.xml · derivative · entry 1 Boyer David W. · CIK 0001909817 · Chief Corp. Affairs Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 45,027 Underlying: Common Stock · 45,027 shares Expires 2033-02-13 F1 · derivative.exercise_date: Represents option of which 1/48th of the shares underlying the option becomes vested and exercisable on March 13, 2023 and an additional 1/48th of the shares underlying the option becomes vested and exercisable each month thereafter. Read SEC document |
| February 13, 2023 Filed Feb 16, 2023 00:06 UTC |
BENEVICH ERICChief Commercial Officer
|
GrantRestricted Stock Unit · Derivative | 8,332 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-009881 · doc4.xml · derivative · entry 2 BENEVICH ERIC · CIK 0001643653 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,332 Underlying: Common Stock · 8,332 shares Expires not disclosed F2 · derivative.exercise_price: Each Restricted Stock Unit represents a contingent right to receive one share of the Issuer Common Stock. F3 · derivative.exercise_date: The Restricted Stock Units will vest annually at 1/4 of the units vesting on each of February 13, 2024, February 13, 2025, February 13, 2026, and February 13, 2027. F3 · derivative.expiration_date: The Restricted Stock Units will vest annually at 1/4 of the units vesting on each of February 13, 2024, February 13, 2025, February 13, 2026, and February 13, 2027. Read SEC document |
| February 13, 2023 Filed Feb 16, 2023 00:06 UTC |
BENEVICH ERICChief Commercial Officer
|
GrantStock Option · Derivative | 51,782 | $0.00 Strike: $103.52 | $0.00 |
DisclosureSEC source: 0001209191-23-009881 · doc4.xml · derivative · entry 1 BENEVICH ERIC · CIK 0001643653 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 51,782 Underlying: Common Stock · 51,782 shares Expires 2033-02-13 F1 · derivative.exercise_date: Represents option of which 1/48th of the shares underlying the option becomes vested and exercisable on March 13, 2023 and an additional 1/48th of the shares underlying the option becomes vested and exercisable each month thereafter. Read SEC document |
| February 13, 2023 Filed Feb 16, 2023 00:04 UTC |
ABERNETHY MATTChief Financial Officer
|
GrantRestricted Stock Unit · Derivative | 10,264 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-009879 · doc4.xml · derivative · entry 2 ABERNETHY MATT · CIK 0001724097 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,264 Underlying: Common Stock · 10,264 shares Expires not disclosed F2 · derivative.exercise_price: Each Restricted Stock Unit represents a contingent right to receive one share of the Issuer Common Stock. F3 · derivative.exercise_date: The Restricted Stock Units will vest annually at 1/4 of the units vesting on each of February 13, 2024, February 13, 2025, February 13, 2026, and February 13, 2027. F3 · derivative.expiration_date: The Restricted Stock Units will vest annually at 1/4 of the units vesting on each of February 13, 2024, February 13, 2025, February 13, 2026, and February 13, 2027. Read SEC document |
| February 13, 2023 Filed Feb 16, 2023 00:04 UTC |
ABERNETHY MATTChief Financial Officer
|
GrantStock Option · Derivative | 63,789 | $0.00 Strike: $103.52 | $0.00 |
DisclosureSEC source: 0001209191-23-009879 · doc4.xml · derivative · entry 1 ABERNETHY MATT · CIK 0001724097 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 63,789 Underlying: Common Stock · 63,789 shares Expires 2033-02-13 F1 · derivative.exercise_date: Represents option of which 1/48th of the shares underlying the option becomes vested and exercisable on March 13, 2023 and an additional 1/48th of the shares underlying the option becomes vested and exercisable each month thereafter. Read SEC document |
| February 08, 2023 Filed Feb 9, 2023 00:56 UTC |
Cooke JulieChief Human Resources Officer
|
SaleCommon Stock | 628 | $103.69 | $65,117.32 |
DisclosureSEC source: 0001209191-23-007917 · doc4.xml · nonDerivative · entry 7 Cooke Julie · CIK 0001776977 · Chief Human Resources Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,424 F3 · kind: The disposition reported in this Form 4 was effected by a broker pursuant to instructions consistent with Rule 10b5-1 trading plan adopted by the Reporting Person at least 60 days prior to the transaction date in Box 3 above. Additionally, Issuer policy restricts the Reporting Person from amending or otherwise modifying any 10b5-1 trading plan subsequent to adoption of the plan. Read SEC document |
| February 08, 2023 Filed Feb 9, 2023 00:56 UTC |
Cooke JulieChief Human Resources Officer
|
SaleCommon Stock | 700 | $103.95 | $72,765.98 |
DisclosureSEC source: 0001209191-23-007917 · doc4.xml · nonDerivative · entry 6 Cooke Julie · CIK 0001776977 · Chief Human Resources Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,052 F9 · kind: Sale of 700 shares of common stock issued upon vesting of 1,328 restricted stock units on February 8, 2022 to cover payroll and withholding taxes, with the balance of the shares (628) maintained by the Reporting Person; the disposition reported in this Form 4 was effected by a broker pursuant to instructions set forth in a Rule 10b5-1 trading plan adopted by the Reporting Person at least 60 days prior to the transaction date in Box 3 above. Additionally, Issuer policy restricts the Reporting Person from amending or otherwise modifying any 10b5-1 trading plan subsequent to adoption of the plan. F10 · price: Represents a weighted average sales price per share. These shares were sold in multiple transactions at prices ranging from $101.58 to $105.72. The Reporting Person has provided to the issuer, and will provide to any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range. Read SEC document |
| February 08, 2023 Filed Feb 9, 2023 00:40 UTC |
ROBERTS EIRYChief Medical Officer
|
SaleCommon Stock | 980 | $104.16 | $102,072.00 |
DisclosureSEC source: 0001209191-23-007916 · doc4.xml · nonDerivative · entry 4 ROBERTS EIRY · CIK 0001727606 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 41,015 F8 · kind: Sale of 980 shares of common stock issued upon vesting of 1,860 restricted stock units on February 8, 2023 to cover payroll and withholding taxes, with the balance of the shares (880) maintained by the Reporting Person; the disposition reported in this Form 4 was effected by a broker pursuant to instructions set forth in a Rule 10b5-1 trading plan adopted by the Reporting Person at least 60 days prior to the transaction date in Box 3 above. Additionally, Issuer policy restricts the Reporting Person from amending or otherwise modifying any 10b5-1 trading plan subsequent to adoption of the plan. F9 · price: Represents a weighted average sales price per share. These shares were sold in multiple transactions at prices ranging from $101.79 to $106.05. The Reporting Person has provided to the issuer, and will provide to any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range. Read SEC document |
| February 08, 2023 Filed Feb 9, 2023 00:35 UTC |
Lloyd-Smith MalcolmChief Integration Officer
|
SaleCommon Stock | 701 | $103.83 | $72,784.55 |
DisclosureSEC source: 0001209191-23-007914 · doc4.xml · nonDerivative · entry 4 Lloyd-Smith Malcolm · CIK 0001557146 · Chief Integration Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 42,337 F8 · kind: Sale of 701 shares of common stock issued upon vesting of 1,328 restricted stock units on February 8, 2023 to cover payroll and withholding taxes, with the balance of the shares (627) maintained by the Reporting Person; the disposition reported in this Form 4 was effected by a broker pursuant to instructions set forth in a Rule 10b5-1 trading plan adopted by the Reporting Person at least 60 days prior to the transaction date in Box 3 above. Additionally, Issuer policy restricts the Reporting Person from amending or otherwise modifying any 10b5-1 trading plan subsequent to adoption of the plan. F9 · price: Represents a weighted average sales price per share. These shares were sold in multiple transactions at prices ranging from $101.58 to $105.72. The Reporting Person has provided to the issuer, and will provide to any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range. Read SEC document |
| February 08, 2023 Filed Feb 9, 2023 00:32 UTC |
Lippoldt DarinChief Legal Officer
|
SaleCommon Stock | 911 | $104.08 | $94,814.97 |
DisclosureSEC source: 0001209191-23-007913 · doc4.xml · nonDerivative · entry 4 Lippoldt Darin · CIK 0001504783 · Chief Legal Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 44,973 F8 · kind: Sale of 911 shares of common stock issued upon vesting of 1,727 restricted stock units on February 8, 2023 to cover payroll and withholding taxes, with the balance of the shares (816) maintained by the Reporting Person; the disposition reported in this Form 4 was effected by a broker pursuant to instructions set forth in a Rule 10b5-1 trading plan adopted by the Reporting Person at least 60 days prior to the transaction date in Box 3 above. Additionally, Issuer policy restricts the Reporting Person from amending or otherwise modifying any 10b5-1 trading plan subsequent to adoption of the plan. F9 · price: Represents a weighted average sales price per share. These shares were sold in multiple transactions at prices ranging from $101.58 to $105.72. The Reporting Person has provided to the issuer, and will provide to any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range. Read SEC document |
| February 08, 2023 Filed Feb 9, 2023 00:28 UTC |
GORMAN KEVIN CHARLESDirector · Chief Executive Officer
|
SaleCommon Stock | 2,274 | $104.30 | $237,184.57 |
DisclosureSEC source: 0001209191-23-007912 · doc4.xml · nonDerivative · entry 4 GORMAN KEVIN CHARLES · CIK 0001201096 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 491,365 F8 · kind: Sale of 2,274 shares of common stock issued upon vesting of 4,317 restricted stock units on February 8, 2023 to cover payroll and withholding taxes, with the balance of the shares (2,043) maintained by the Reporting Person; the disposition reported in this Form 4 was effected by a broker pursuant to instructions set forth in a Rule 10b5-1 trading plan adopted by the Reporting Person at least 60 days prior to the transaction date in Box 3 above. Additionally, Issuer policy restricts the Reporting Person from amending or otherwise modifying any 10b5-1 trading plan subsequent to adoption of the plan. F9 · price: Represents a weighted average sales price per share. These shares were sold in multiple transactions at prices ranging from $101.72 to $105.79. The Reporting Person has provided to the issuer, and will provide to any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range. Read SEC document |
| February 08, 2023 Filed Feb 9, 2023 00:25 UTC |
Gano KyleChief Business Development Off
|
SaleCommon Stock | 980 | $103.99 | $101,910.00 |
DisclosureSEC source: 0001209191-23-007910 · doc4.xml · nonDerivative · entry 4 Gano Kyle · CIK 0001567160 · Chief Business Development Off 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 128,096 F8 · kind: Sale of 980 shares of common stock issued upon vesting of 1,860 restricted stock units on February 8, 2023 to cover payroll and withholding taxes, with the balance of the shares (880) maintained by the Reporting Person; the disposition reported in this Form 4 was effected by a broker pursuant to instructions set forth in a Rule 10b5-1 trading plan adopted by the Reporting Person at least 60 days prior to the transaction date in Box 3 above. Additionally, Issuer policy restricts the Reporting Person from amending or otherwise modifying any 10b5-1 trading plan subsequent to adoption of the plan. F9 · price: Represents a weighted average sales price per share. These shares were sold in multiple transactions at prices ranging from $101.53 to $105.71. The Reporting Person has provided to the issuer, and will provide to any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.